Protein and Peptide Arrays for Studying Autoimmunity
Professor Paul J. (P.J.) Utz, Stanford University, speaking at Microarray World Congress.
The Potassium Channels Kv1.3 and KCa3.1 as Targets for Inflammatory Brain Pathologies
Professor Heike Wulff, University of California, speaking at Ion Channel Targets 2011.
Alpha2* Nicotinic Acetylcholine Receptors as a Therapeutic Target for Memory Enhancement
Dr Katumi Sumikawa, University of California, speaking at Ion Channel Targets 2011.
Smooth Muscle Kv7 (KCNQ) Potassium Channels: Important New Therapeutic Targets
Professor Kenneth Byron, Loyola University Chigaco, speaking at Ion Channel Targets 2011.
A Systematic Investigation of Candidate Breast Cancer Progression-Associated Biomarkers Identified from Omic Screens: Leveraging Antibody-Based Proteomics
Prof. William Gallagher, Chief Scientific Officer at OncoMark, speaking at Advances in Microarray Technology 2011.
3D-Gel Electrophoresis, a New Development in Protein Analysis
Robert Ventzki, University of Greifswald, speaking at Advances in Separation Technology 2011.
Quantitative Proteomics For Biomarker Discovery and Validation: Prostate Cancer Case Study
Stephen Pennington, UCD Dublin, Professor of Proteomics, speaking at European Biomarkers Summit 2011.
Genome-scale Quantitative Tumour Proteomics for Cancer Biomarkers Discovery
Metodi Metodiev, Lecturer/Director of Proteomics Unit, University of Essex, speaking at European Biomarkers Summit 2011.
Mode of Action Analysis and Biomarker Discovery Using Mass Spectrometry-Based Phosphoproteomics Technologies
Andreas Jenne, CEO, Kinaxo, speaking at European Biomarkers Summit 2011.